HROW
Harrow, Inc.
9.77
USD
This page is just a preview of the data found in TrendSpider’s full version
Harrow, Inc. stock is down -23.79% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52.94% of the previous 16 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 10 PUTs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 01 Nov 14:07 | 17 Nov, 2023 | 15.00 | 3429 | ||
| 01 Nov 15:34 | 17 Nov, 2023 | 15.00 | 3429 | ||
| 01 Nov 19:38 | 17 Nov, 2023 | 15.00 | 3429 | ||
| 02 Nov 17:52 | 17 Nov, 2023 | 15.00 | 4229 | ||
| 03 Nov 16:24 | 17 Nov, 2023 | 15.00 | 4729 | ||
| 06 Nov 19:09 | 17 Nov, 2023 | 15.00 | 5029 | ||
| 06 Nov 19:49 | 17 Nov, 2023 | 15.00 | 5029 | ||
| 06 Nov 20:53 | 17 Nov, 2023 | 15.00 | 5029 | ||
| 08 Nov 20:38 | 17 Nov, 2023 | 15.00 | 5449 | ||
| 14 Nov 14:53 | 17 Nov, 2023 | 12.50 | 106 |
Harrow Health, Inc. owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases.
